Profacgen has a mature EMSA experiment platform and extensive experience in nucleotide-protein binding analysis. We perform strict examination on both nucleotide and protein to ensure they are qualified for EMSA before the initiation of each project. We can use radioactive isotope and also other labeling agents such as biotin and FAM to label nucleotides. Unlabeled nucleotides are used as specific competitors to eliminate non-specific nucleotide-protein interactions. We also have advanced instrument for signal detection ensuring high sensitive and high signal-to-noise ratio results.

https://www.profacgen.com/Electrophoretic-Mobility-Shift-Assay-EMSA-Service.htm

Profacgen offers a full range of biopharmaceutical development and bio-manufacturing services that cover strategic consultancy, world-class process development, cGMP manufacturing, and analytical development.